US STOCKS- Positive earnings boost futures after Monday's selloff

Published 25/02/2020, 14:23
Updated 25/02/2020, 14:27
© Reuters.  US STOCKS- Positive earnings boost futures after Monday's selloff

(For a live blog on the U.S. stock market, click LIVE/ or

type LIVE/ in a news window)

* Futures up: Dow 0.42%, S&P 0.37%, Nasdaq 0.65%

By Medha Singh

Feb 25 (Reuters) - U.S. stock index futures edged higher on

Tuesday, helped by a slate of positive earnings, a day after the

S&P 500 and the Dow Industrials logged their worst session in

two years on worries over the worldwide spread of the virus.

Shares of Dow-member Home Depot Inc HD.N rose 2.5% in

premarket trading after the home improvement chain beat

quarterly sales and profit estimates. Another upbeat report in the retail space was from

department store operator Macy's Inc M.N , which jumped more

than 5% after a smaller-than-expected drop in quarterly

same-store sales.

HP Inc HPQ.N gained 4% after the company said it would

step up efforts to slash costs and buy back stock, as it seeks

investor support to defend against a $35 billion takeover offer

from U.S. printer maker Xerox Holdings Corp XRX.N .

The positive fourth-quarter earnings along with hopes of a

limited damage from the outbreak had fueled Wall Street's run to

record highs until last week.

U.S. stock indexes have declined in the past three sessions

with fears of a pandemic knocking off more than 3% on Monday

after a flare up in infections in several countries.

As of Monday's close, the S&P 500 .SPX and the Dow Jones

Industrials .DJI had erased their gains for the year.

At 7:43 a.m. ET, Dow e-minis 1YMcv1 were up 118 points, or

0.42%. S&P 500 e-minis EScv1 were up 12 points, or 0.37% and

Nasdaq 100 e-minis NQcv1 were up 59 points, or 0.65%.

The CBOE volatility index .VIX , an options-based gauge of

investor anxiety, was down 1.86 points after hitting its highest

level since January 2019 on Monday.

Among other stocks, Perrigo PRGO.K jumped 10.6% after the

drugmaker gained the first U.S. approval for a generic version

of Teva Pharmaceutical Industries Ltd's TEVA.TA respiratory

drug, ProAir.

Mastercard Inc MA.N shares fell 2.2% after the company

said Chief Executive Officer Ajay Banga will step down at the

start of the next year and be replaced by products head Michael

Miebach. Shares of rival Visa Inc V.N dropped 1.3%.

Investors will also keep an eye on the Conference Board's

consumer confidence data for February, scheduled for 10:00 a.m.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.